The Immunological Factors Predisposing to Severe Covid-19 Are Already Present in Healthy Elderly and Men.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Ter Horst, Rob
Koeken, Valerie A C M
Moorlag, Simone J C F M
Mourits, Vera P
de Bree, Charlotte
Joosten, Leo A B
Netea, Mihai G
MetadataShow full item record
AbstractMale sex and old age are risk factors for COVID-19 severity, but the underlying causes are unknown. A possible explanation for this might be the differences in immunological profiles in males and the elderly before the infection. With this in mind, we analyzed the abundance of circulating proteins and immune populations associated with severe COVID-19 in 2 healthy cohorts. Besides, given the seasonal profile of COVID-19, the seasonal response against SARS-CoV-2 could also be different in the elderly and males. Therefore, PBMCs of female, male, young, and old subjects in different seasons of the year were stimulated with heat-inactivated SARS-CoV-2 to investigate the season-dependent anti-SARS-CoV-2 immune response. We found that several T cell subsets, which are known to be depleted in severe COVID-19 patients, were intrinsically less abundant in men and older individuals. Plasma proteins increasing with disease severity, including HGF, IL-8, and MCP-1, were more abundant in the elderly and males. Upon in vitro SARS-CoV-2 stimulation, the elderly produced significantly more IL-1RA and had a dysregulated IFNγ response with lower production in the fall compared with young individuals. Our results suggest that the immune characteristics of severe COVID-19, described by a differential abundance of immune cells and circulating inflammatory proteins, are intrinsically present in healthy men and the elderly. This might explain the susceptibility of men and the elderly to SARS-CoV-2 infection.
CitationFront Immunol. 2021 Aug 9;12:720090. doi: 10.3389/fimmu.2021.720090.
AffiliationCiiM, Zentrum für individualisierte Infektionsmedizin, Feodor-Lynen-Str.7, 30625 Hannover.
JournalFrontiers in immunology
The following license files are associated with this item:
- Creative Commons
- Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment.
- Authors: Liu J, Yang X, Wang H, Li Z, Deng H, Liu J, Xiong S, He J, Feng X, Guo C, Wang W, Zelinskyy G, Trilling M, Sutter K, Senff T, Menne C, Timm J, Zhang Y, Deng F, Lu Y, Wu J, Lu M, Yang D, Dittmer U, Wang B, Zheng X
- Issue date: 2021 Apr 27
- Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.
- Authors: Costagliola G, Spada E, Consolini R
- Issue date: 2021 Jun
- Sex- and age-specific clinical and immunological features of coronavirus disease 2019.
- Authors: Jin S, An H, Zhou T, Li T, Xie M, Chen S, Chen C, Ying B, Xu Z, Li X, Li M
- Issue date: 2021 Mar
- Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
- Authors: Horspool AM, Kieffer T, Russ BP, DeJong MA, Wolf MA, Karakiozis JM, Hickey BJ, Fagone P, Tacker DH, Bevere JR, Martinez I, Barbier M, Perrotta PL, Damron FH
- Issue date: 2021 Jan 20
- Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
- Authors: Lafon E, Diem G, Witting C, Zaderer V, Bellmann-Weiler RM, Reindl M, Bauer A, Griesmacher A, Fux V, Hoermann G, Miller C, Zabernigg A, Wöll E, Wilflingseder D, Lass-Flörl C, Posch W
- Issue date: 2021